Gracie has autism, a condition that affected nearly every aspect of her family’s life after she was diagnosed at 2. But a new study is offering hope for the Gregorys and families like them.
The results were impressive: More than two-thirds of the children showed reported improvements. A larger second trial is underway, one its researchers hope will lead to long-term treatment for children with autism.
Skeptics say there are too many unanswered questions to get excited. Even Duke researchers acknowledge as much. The initial trial, published Wednesday in the journal Stem Cells Translational Medicine, was a safety study, not a controlled, double-blind study with definitive proof of positive results. This study was open-label, meaning everyone — the doctors and the families — knew that the therapy was being administered.
But for the Gregorys, the change in their daughter has been monumental
MORE INFORMATION edition.cnn.com